Infineon Technologies AG (XETR:IFX) scored a US ITC victory as import and sales bans block Innoscience’s infringing GaN products, even as investor Morgan Stanley disclosed surpassing a 3% voting-rights stake in Infineon, underscoring legal and shareholder momentum for the company.
Previous Week Recap
- Infineon GaN Patent Win: Infineon’s GaN patent win: US ITC upholds ruling that Innoscience infringed, and after review, import and sales bans block Innoscience’s infringing GaN products from US market.
- Morgan Stanley Surpasses Threshold: Morgan Stanley surpassed the 3% voting-rights threshold in Infineon Technologies (IFX) on June 29, 2026; the filing was published EU-wide on July 6, 2026.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.